NAFLDsym is a quantitative systems pharmacology (QSP) modeling software to support the development of treatments for non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). NAFLDsym has been used by numerous drug development programs to help with decision-making regarding proposed targets, combination therapies, competitor molecules, trial design, and much more.
Join us for this exciting webinar focused on NAFLDsym use cases. Several new case studies will be shared by multiple presenters. Bring your questions about how NAFLDsym could possibly apply to your program!